Forward Pharma (FWP) Says It's Disappointed with European Patent Office Decision to Revoke '355 Patent

January 29, 2018 10:45 AM

Forward Pharma A/S (NASDAQ: FWP) (“Forward” or the “Company”) today announced that the European Patent Office (the “EPO”) has revoked ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found